Texas
LATEST FROM BIOSPACE
Please check out the biopharma industry’s COVID-19 stories that are trending for June 8, 2021.
The three companies will aim to develop their different programs such as Stablix TPS platform, Stellanova’s focused on targeting pro-tumorigenic effects, and Amyl’s development of preclinical therapeutic candidates.
There were seven initial public offerings (IPOs) for biotech companies in the month of May. Here’s a look.
Biopharma and life sciences companies strengthen their leadership teams and board with these Movers & Shakers.
Please check out the biopharma industry’s COVID-19 stories that are trending for May 18, 2021.
The company has raised approximately $1.3 billion in external financing over the past three years, including $310 million in 2020.
Please check out the biopharma industry’s COVID-19 stories that are trending for May 11, 2021.
Please check out the biopharma industry’s COVID-19 stories that are trending for May 4, 2021.
Texas is quickly becoming a hotbed of biopharmaceutical activities, with Houston being one of the two top cities in the state that is leading the way.
There are several experimental treatments undergoing study for types of melanoma. BioSpace rounds up some of the most recent clinical news in this space.
PRESS RELEASES